Back to all Events

Crohn's & Colitis Foundation -- IBD Innovate 2018 Conference

November 13, 2018

As publicly released, Innovation Pharmaceuticals will be presenting a scientific poster on the planned continued development of Brilacidin for Inflammatory Bowel Disease at the inaugural “IBD Innovate 2018” conference.

The day-long conference, hosted by the Crohn’s & Colitis Foundation and sponsored, in part, by Celgene Corporation, will be held on November 13, 2018, at the New York Academy of Medicine located in New York, NY. Additional conference details can be found on the Crohn’s & Colitis Foundation website, or by clicking here.

The scientific poster—titled “Brilacidin for Inflammatory Bowel Disease: A Novel, Non-Corticosteroid, Non-Biologic Drug Candidate in Clinical Development”—will be available here on November 13, 2018.